コンテンツへスキップ
Merck
  • Systemic influences contribute to prolonged microvascular rarefaction after brain irradiation: a role for endothelial progenitor cells.

Systemic influences contribute to prolonged microvascular rarefaction after brain irradiation: a role for endothelial progenitor cells.

American journal of physiology. Heart and circulatory physiology (2014-07-20)
Nicole M Ashpole, Junie P Warrington, Matthew C Mitschelen, Han Yan, Danuta Sosnowska, Tripti Gautam, Julie A Farley, Anna Csiszar, Zoltan Ungvari, William E Sonntag
要旨

Whole brain radiation therapy (WBRT) induces profound cerebral microvascular rarefaction throughout the hippocampus. Despite the vascular loss and localized cerebral hypoxia, angiogenesis fails to occur, which subsequently induces long-term deficits in learning and memory. The mechanisms underlying the absence of vessel recovery after WBRT are unknown. We tested the hypotheses that vascular recovery fails to occur under control conditions as a result of loss of angiogenic drive in the circulation, chronic tissue inflammation, and/or impaired endothelial cell production/recruitment. We also tested whether systemic hypoxia, which is known to promote vascular recovery, reverses these chronic changes in inflammation and endothelial cell production/recruitment. Ten-week-old C57BL/6 mice were subjected to a clinical series of fractionated WBRT: 4.5-Gy fractions 2 times/wk for 4 wk. Plasma from radiated mice increased in vitro endothelial cell proliferation and adhesion compared with plasma from control mice, indicating that WBRT did not suppress the proangiogenic drive. Analysis of cytokine levels within the hippocampus revealed that IL-10 and IL-12(p40) were significantly increased 1 mo after WBRT; however, systemic hypoxia did not reduce these inflammatory markers. Enumeration of endothelial progenitor cells (EPCs) in the bone marrow and circulation indicated that WBRT reduced EPC production, which was restored with systemic hypoxia. Furthermore, using a bone marrow transplantation model, we determined that bone marrow-derived endothelial-like cells home to the hippocampus after systemic hypoxia. Thus, the loss of production and homing of EPCs have an important role in the prolonged vascular rarefaction after WBRT.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
スクロース, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
スクロース, ≥99.5% (GC)
Sigma-Aldrich
スクロース, ≥99.5% (GC), BioXtra
Sigma-Aldrich
スクロース, BioUltra, for molecular biology, ≥99.5% (HPLC)
USP
スクロース, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
オクタン, reagent grade, 98%
Sigma-Aldrich
エチレンジアミン四酢酸 溶液, 0.02% in DPBS (0.5 mM), sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
スクロース, ≥99.5% (GC), BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
エチレンジアミン四酢酸, anhydrous, crystalline, BioReagent, suitable for cell culture
Sigma-Aldrich
エチレンジアミン四酢酸, 99.995% trace metals basis
Sigma-Aldrich
スクロース, Grade I, ≥99% (GC), suitable for plant cell culture
Sigma-Aldrich
エチレンジアミン四酢酸, ACS reagent, 99.4-100.6%, powder
Sigma-Aldrich
エチレンジアミン四酢酸, anhydrous, BioUltra, ≥99% (titration)
Sigma-Aldrich
エチレンジアミン四酢酸 二ナトリウム塩 溶液, BioUltra, for molecular biology, pH 8.0, ~0.5 M in H2O
Supelco
スクロース, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
オクタン, electronic grade, ≥99.999% metals basis, ≥99% (CP)
Sigma-Aldrich
オクタン, anhydrous, ≥99%
Sigma-Aldrich
スクロース, ACS reagent
Sigma-Aldrich
エチレンジアミン四酢酸, purified grade, ≥98.5%, powder
Sigma-Aldrich
スクロース, JIS special grade
Supelco
オクタン, analytical standard
Millipore
スクロース, suitable for microbiology, ACS reagent, ≥99.0%
Sigma-Aldrich
スクロース, puriss., meets analytical specification of Ph. Eur., BP, NF
Sigma-Aldrich
エチレンジアミン四酢酸, ≥98.0% (KT)
Sigma-Aldrich
エチレンジアミン四酢酸, BioUltra, ≥99.0% (KT)
Supelco
スクロース, analytical standard, for enzymatic assay kit SCA20
スクロース, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
エチレンジアミン四酢酸, SAJ special grade, ≥99.0%
Sigma-Aldrich
スクロース, SAJ first grade